Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-Dose, Ivermectin-Controlled, Double-Blind, Efficacy, Safety And Tolerability Study Of Orally Administered Moxidectin In Subjects Infected With Onchocerca Volvulus

NCT00790998 is registered in ClinicalTrials.gov with Medicines Development for Global Health as lead sponsor.

NCT NCT00790998
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00790998 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-Dose, Ivermectin-Controlled, Double-Blind, Efficacy, Safety And Tolerability Study Of Orally Administered Moxidectin In Subjects Infected With Onchocerca Volvulus
Lead sponsor
Medicines Development for Global Health
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2009
Completion date
May 31, 2012
Enrollment
1,497 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

onchocerciasis